 |
 |
 |
 |
 |
Genome Diagnostics, Inc. is a privately held company dedicated to the discovery, development and commercialization of clinical
diagnostic tests for cancer patient prognosis and prediction of therapeutic response as tools for the advancement of personalized
cancer therapy.
Our goal is to discover molecular traces that Nature has artfully hid in the abyss of biological data.
Think about it as the Easter egg hunt for molecular blueprints all year round.
To hear about new developments as they happen, please, do not hesitate to contact us.
|
|
